Prostate cancer screening using prostate-specific antigen (PSA) shows high sensitivity but low cancer detection rates in men aged 50-75. Further evaluation is needed to determine nationwide screening feasibility due to cost and yield.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: